|
Delayed
NSE India S.E.
05:14:50 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 2,892.60 INR | +0.66% |
|
+1.78% | +67.94% |
| 08-14 | Gland Pharma Names Dr. Reddy's Executive as CEO | MT |
| 08-13 | Gland Pharma Limited Announces Appointment of Deepak Sapra to Chief Executive Officer, Effective November 16, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- GLAND Stock
- Consensus Gland Pharma Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
